Table 5.
Differences between groups of cost and cost/effectiveness(C/E) in the treatment of infectious complications
| Multimodal EON group (n = 53) |
Conventional care group (n = 54) |
P value | |
|---|---|---|---|
| Median cost of nutritional support/patient (IQR) | 450.0 (426.7, 462.8) | 496.8 (466.9, 526.4) | <0.001 |
| Median cost of nutritional support/patient/day (IQR) | 69.7 (61.8, 79.9) | 67.2 (53.1, 78.6) | 0.497 |
| Median total cost of treatment/patient (C) (IQR) | 456.4 (429.7, 500.3) | 509.6 (474.5, 567.5) | <0.001 |
| Effectiveness (E) | 84.9% | 79.9% | 0.475 |
| Cost/effectiveness (C/E) (IQR) | 537.6 (506.1, 589.3) | 637.8 (593.9, 710.3) | <0.001 |
| Incremental cost-effectiveness ratio | 1064 |
EON early oral nutrition, IQR interquartile ranges, C cost, E effectiveness